LOXL3 relevance in melanoma is further supported by a recent analysis of 373 biopsies that correlates LOXL3 expression with tumor progression, invasion, and worse prognosis of primary melanoma patients [39]. The gene discussed is LOXL3; the disease is neoplasm.